|
| Category | Funding IC | Project Number | Sub Project # | Project Title | PI Name | Org Name | State / Country | Amount |
|
Brain Cancer
|
NCI
|
5R01CA104922-04
|
|
Phenolic antioxidants as tumor radio/chemosensitizers
|
KOUMENIS, CONSTANTINOS
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$261,121
|
|
Brain Cancer
|
NCI
|
2R01CA086832-06A2
|
|
MOLECULAR DETERMINANTS OF BRAIN-METASTATIC MELANOMA
|
MARCHETTI, DARIO
|
BAYLOR COLLEGE OF MEDICINE
|
TX
|
$279,192
|
|
Brain Cancer
|
NCI
|
5K08CA116429-03
|
|
Creation of AlkB Mutants for Protection of Bone Marrow
|
CAMPS, MANEL
|
UNIVERSITY OF CALIFORNIA SANTA CRUZ
|
CA
|
$132,532
|
|
Brain Cancer
|
NCI
|
5K08CA101954-03
|
|
Chemokine Secreting Dendritic Cells for Glioma Immunotherapy
|
SLOAN, ANDREW
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$135,426
|
|
Brain Cancer
|
NINDS
|
5U01NS050094-03
|
|
Characterizing Beta Lactams as Neuroprotectants for Amyotrophic Lateral Sclerosis
|
ROTHSTEIN, JEFFREY
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$322,944
|
|
Brain Cancer
|
NCI
|
1R21CA114279-01A2
|
|
MRI Assessment of Anti-angiogenesis in Mouse Gliomas
|
PIKE, MARTIN
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$173,250
|
|
Brain Cancer
|
NCI
|
5F31CA123711-02
|
|
Targeting ATF5 for intervention in brain cancer
|
ARIAS, ANGELO
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$30,513
|
|
Brain Cancer
|
NCI
|
5R01CA114567-03
|
|
Targeted therapy in ex vivo medulloblastoma/PNET
|
OLSON, JAMES
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$223,417
|
|
Brain Cancer
|
NCI
|
5R01CA118261-03
|
|
Molecular Requirements for Recombinant Cytotoxins Efficacy
|
DEBINSKI, WALDEMAR
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$243,842
|
|
Brain Cancer
|
NCI
|
5U01CA062405-14
|
|
NABTC Member Institution Grant (UCSF Project Leader)
|
LIEBERMAN, FRANK
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$58,706
|
|
Brain Cancer
|
NCI
|
5R01CA033895-26
|
|
Glycoproteins in Neural Cells and Cancer
|
FUKUDA, MINORU
|
BURNHAM INSTITUTE FOR MEDICAL RESEARCH
|
CA
|
$318,067
|
|
Brain Cancer
|
NCI
|
5U01CA062432-14
|
|
NEW APPLICATIONS IN BRAIN TUMOR THERAPY
|
MIKKELSEN, TOM
|
HENRY FORD HEALTH SYSTEM
|
MI
|
$131,442
|
|
Brain Cancer
|
NIMH
|
5R01MH067916-05
|
|
Control of Cerebellar Development by FGF signaling
|
WECHSLER-REYA, ROBERT
|
DUKE UNIVERSITY
|
NC
|
$295,691
|
|
Brain Cancer
|
NCI
|
5U01CA062474-14
|
|
NEW APPROACHES TO BRAIN TUMOR THERAPY-(NABTT)
|
BREM, HENRY
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$119,036
|
|
Brain Cancer
|
NCI
|
5U01CA062407-14
|
|
Therapeutics Studies of Primary CNS Malignancies
|
WEN, PATRICK
|
DANA-FARBER CANCER INSTITUTE
|
MA
|
$142,136
|
|
Brain Cancer
|
NCI
|
5R01CA112519-03
|
|
Novel Targeted Therapeutics for Cental Nervous System Malignancies
|
ALI-OSMAN, FRANCIS
|
DUKE UNIVERSITY
|
NC
|
$327,069
|
|
Brain Cancer
|
NCI
|
4R37CA011898-38
|
|
Brain Tumors - Immunological and Biological Studies
|
BIGNER, DARELL
|
DUKE UNIVERSITY
|
NC
|
$670,357
|
|
Brain Cancer
|
NCI
|
5R01CA081255-08
|
|
Novel Convergence of Medulloblastoma Mechanisms via REST
|
MAJUMDER, SADHAN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$236,267
|
|
Brain Cancer
|
NCI
|
5R21CA117152-02
|
|
Vaccination With Peptide-loaded alphaDC1s For Malignant Gliomas
|
OKADA, HIDEHO
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$282,150
|
|
Brain Cancer
|
NCI
|
5U01CA105663-05
|
|
Participating Member Institution in NABTC
|
DEANGELIS, LISA
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
NY
|
$169,613
|
|
Brain Cancer
|
NCI
|
5U01CA076607-10
|
|
Therapeutic Studies of Anaplastic Gliomas
|
NABORS, LOUIS
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$119,037
|
|
Brain Cancer
|
NCI
|
5U01CA062412-14
|
|
NABTC - M.D. Anderson Clinical Center
|
GILBERT, MARK
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$141,872
|
|
Brain Cancer
|
NCI
|
5U01CA105689-05
|
|
Phamacokinetics Center for the NABTT CNS Consortium
|
SUPKO, JEFFREY
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$189,873
|
|
Brain Cancer
|
NCI
|
5U01CA105706-05
|
|
Therapeutic Studies of Primary CNS Malignancies-NABTT
|
BARNETT, GENE
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
OH
|
$70,948
|
|
Brain Cancer
|
NCI
|
5R01CA120813-02
|
|
Modulation of Microglia and T Cell Interactions in Malignant Glioma
|
HEIMBERGER, AMY
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$263,340
|
|
Brain Cancer
|
NCI
|
5R01CA114587-04
|
|
Neuroinflammation in CNS Radiation Injury: IL-1 & COX-2
|
O'BANION, MICHAEL
|
UNIVERSITY OF ROCHESTER
|
NY
|
$292,135
|
|
Brain Cancer
|
NINDS
|
5R37NS033642-14
|
|
Regulation of CNS and Limb Polarity by Sonic Hedgehog
|
MCMAHON, ANDREW
|
HARVARD UNIVERSITY
|
MA
|
$751,317
|
|
Brain Cancer
|
NCI
|
5U01CA062406-14
|
|
NABTT-New Approaches to Brain Tumor Therapy (CNSC)
|
BATCHELOR, TRACY
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$57,838
|
|
Brain Cancer
|
NCI
|
5R01CA057683-15
|
|
Toward a molecular classification of human gliomas
|
LOUIS, DAVID
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$298,678
|
|
Brain Cancer
|
NCI
|
5R01CA124756-02
|
|
Targeting Translation Control in Malignant Glioma
|
GROMEIER, MATTHIAS
|
DUKE UNIVERSITY
|
NC
|
$266,760
|
|
Brain Cancer
|
NICHD
|
5R01HD049888-03
|
|
Neural Correlates of Reading in Medulloblastoma Survivor
|
OGG, ROBERT
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
TN
|
$387,306
|
|
Brain Cancer
|
NINDS
|
5R01NS055304-02
|
|
NRAGE: A mediator of p38 map kinase and caspase activity in the CNS.
|
VERDI, JOSEPH
|
MAINE MEDICAL CENTER
|
ME
|
$335,563
|
|
Brain Cancer
|
NINDS
|
5R01NS051557-03
|
|
Neural precursor cell therapy for disseminated glioma
|
THOMPSON, REID
|
VANDERBILT UNIVERSITY
|
TN
|
$301,824
|
|
Brain Cancer
|
NCI
|
5R01CA114422-03
|
|
Efficacy and toxicity of TRAIL against gliomas
|
PUDUVALLI, VINAY
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$181,692
|
|
Brain Cancer
|
NCI
|
5R01CA112397-03
|
|
Post-transcriptional Regulation Requires Phosphorylation of HuR in Glioma
|
NABORS, LOUIS
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$225,695
|
|
Brain Cancer
|
NCI
|
5U01CA105695-05
|
|
Consortium Therapeutic Studies of Primary Central Nervous System Malignancies
|
CLOUGHESY, TIMOTHY
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$146,647
|
|
Brain Cancer
|
NINDS
|
5R01NS050151-04
|
|
Glioblastoma - Molecular Analysis for Clinical Trials
|
MISCHEL, PAUL
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$338,768
|
|
Brain Cancer
|
NCI
|
5U01CA062422-14
|
|
NABTC Member Intitution Grant (UCSF Project Leader)
|
CHANG, SUSAN
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$138,276
|
|
Brain Cancer
|
NINDS
|
5R01NS021716-23
|
|
EGFRvIII and PTEN Loss Transform Neural Precursor Cells
|
ROSS, ALONZO
|
UNIV OF MASSACHUSETTS MED SCH WORCESTER
|
MA
|
$355,022
|
|
Brain Cancer
|
NINDS
|
5R01NS053468-02
|
|
Nanoparticle MR Imaging of BBB Inflammation at High Tesla in CNS Tumors
|
NEUWELT, EDWARD
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$544,834
|
|
Brain Cancer
|
NINDS
|
5R01NS055126-02
|
|
The Fn14 Receptor and Brain Tumor Invasion
|
WINKLES, JEFFREY
|
UNIVERSITY OF MARYLAND BALTIMORE
|
MD
|
$324,844
|
|
Brain Cancer
|
NHLBI
|
5R01HL073396-07
|
|
Role of Src family kinases in endothelial cell biology
|
ELICEIRI, BRIAN
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$347,625
|
|
Brain Cancer
|
NCI
|
5R01CA075979-10
|
|
MECHANISMS FOR PITUITARY TUMORIGENESIS
|
MELMED, SHLOMO
|
CEDARS-SINAI MEDICAL CENTER
|
CA
|
$266,250
|
|
Brain Cancer
|
NINDS
|
5R21NS054143-02
|
|
Targeted Toxin for Brain Cancer Gene Therapy
|
CASTRO, MARIA
|
CEDARS-SINAI MEDICAL CENTER
|
CA
|
$208,688
|
|
Brain Cancer
|
NLM
|
1R21LM009706-01
|
|
Integrating Genomic Data and Biological Knowledge to Learn Context-Specific Gene
|
KIM, SEUNGCHAN
|
ARIZONA STATE UNIVERSITY-TEMPE CAMPUS
|
AZ
|
$183,012
|
|
Brain Cancer
|
NCI
|
5R01CA106630-05
|
|
The role of p53 in remodeling DNA methylation in cancer
|
TAYLOR, SHIRLEY
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
VA
|
$244,189
|
|
Brain Cancer
|
NCI
|
5R21CA123867-02
|
|
Phase I and Biological Studies of DB67 - A Blood Stable Camptothecin
|
LEGGAS, MARKOS
|
UNIVERSITY OF KENTUCKY
|
KY
|
$205,100
|
|
Brain Cancer
|
NCI
|
5R01CA020525-32
|
|
Regulation of cell growth and proliferation by Myc
|
EISENMAN, ROBERT
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$571,945
|
|
Brain Cancer
|
NIGMS
|
5R01GM072855-05
|
|
Genetic Regulatory Networks: Comp. & Ext. Investigations
|
SHMULEVICH, ILYA
|
INSTITUTE FOR SYSTEMS BIOLOGY
|
WA
|
$205,945
|
|
Brain Cancer
|
NCI
|
5R01CA109196-04
|
|
"Regulation of Glioma Cell Apoptosis in PKCDelta"
|
BRODIE, CHAYA
|
HENRY FORD HEALTH SYSTEM
|
MI
|
$242,696
|
|
Brain Cancer
|
NCI
|
5R01CA105171-05
|
|
Combining Virotherapy and Immunotherapy for Cancer
|
KASAHARA, NORIYUKI
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$300,313
|
|
Brain Cancer
|
NCI
|
5R01CA086335-07
|
|
Therapeutic modulation of angiogenesis in human gliomas
|
VAN MEIR, ERWIN
|
EMORY UNIVERSITY
|
GA
|
$318,638
|
|
Brain Cancer
|
NINDS
|
5R01NS054193-02
|
|
Gene Therapy and the Brain: Neuroimmune Interactions
|
LOWENSTEIN, PEDRO
|
CEDARS-SINAI MEDICAL CENTER
|
CA
|
$313,031
|
|
Brain Cancer
|
NINDS
|
7K08NS046461-05
|
|
Gene Expression in Brain Tumor Angiogenesis
|
WALTER, KEVIN
|
UNIVERSITY OF ROCHESTER
|
NY
|
$176,969
|
|
Brain Cancer
|
NCI
|
1R01CA130940-01
|
|
Targeting the Fn14-Rac1 signaling pathway in invasive gliomas
|
TRAN, NHAN
|
TRANSLATIONAL GENOMICS RESEARCH INST
|
AZ
|
$300,668
|
|
Brain Cancer
|
NCI
|
5R01CA116020-03
|
|
Inhibitor-sensitive and -resistant EGFR mutants from lung cancer and glioblastoma
|
MEYERSON, MATTHEW
|
DANA-FARBER CANCER INSTITUTE
|
MA
|
$326,489
|
|
Brain Cancer
|
NCI
|
5R01CA100011-05
|
|
P38, G2 Arrest, and Temozolomide Resistance in Gliomas
|
PIEPER, RUSS
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$303,277
|
|
Brain Cancer
|
NCI
|
5R01CA064462-12
|
|
GlcNAcT-V Regulation of Cell Surface Structure/Function
|
PIERCE, J
|
UNIVERSITY OF GEORGIA (UGA)
|
GA
|
$352,110
|
|
Brain Cancer
|
NCI
|
5R01CA107070-05
|
|
RGD-Polymer Targeting Plasmid to Angiogenic Endothelium
|
KIM, SUNG WAN
|
UNIVERSITY OF UTAH
|
UT
|
$261,534
|
|
Brain Cancer
|
NINDS
|
5R01NS056218-03
|
|
Effects of Radiation on Brain Microvasculature and Cognition
|
SONNTAG, WILLIAM
|
UNIVERSITY OF OKLAHOMA HLTH SCIENCES CTR
|
OK
|
$351,506
|
|
Brain Cancer
|
NCI
|
5R21CA121539-02
|
|
Change Detection in Serial MRIs of Patients with Brain Gliomas
|
ERICKSON, BRADLEY
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
MN
|
$148,000
|
|
Brain Cancer
|
NCI
|
7R01CA114205-03
|
|
Allergies, Genetic Susceptibility and Adult Glioma Risk
|
MICHAUD, DOMINIQUE
|
U OF L IMPERIAL COL OF SCI/TECHNLGY/MED
|
UK
|
$371,078
|
|
Brain Cancer
|
NINDS
|
5R25NS054767-03
|
|
Neurobiology of Disease -- Teaching Workshop
|
KRIEGSTEIN, ARNOLD
|
SOCIETY FOR NEUROSCIENCE
|
DC
|
$54,365
|
|
Brain Cancer
|
NCI
|
5R01CA039742-24
|
|
Epidemiology of Cancer in a Cohort of Older Women
|
FOLSOM, AARON
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$522,496
|
|
Brain Cancer
|
NCI
|
1R21CA131980-01
|
|
In vivo imaging and therapeutic efficacy of NSC-secreted nanobodies
|
SHAH, KHALID
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$236,417
|
|
Brain Cancer
|
NINDS
|
5R01NS051625-04
|
|
Radiation effects of MMPs in glioma angiogenesis
|
MOHANAM, SANJEEVA
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$237,903
|
|
Brain Cancer
|
NCI
|
5R01CA110384-04
|
|
PKA modulation of hedgehog: mouse medulloblastoma model
|
WASCHEK, JAMES
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$286,387
|
|
Brain Cancer
|
NINDS
|
5R01NS037704-10
|
|
Molecular Markers as Predictors of Outcome in Gliomas
|
POLLACK, IAN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$324,435
|
|
Brain Cancer
|
NINDS
|
5R01NS032677-16
|
|
Genetically Engineered Viruses for Brain Tumor Therapy
|
MARTUZA, ROBERT
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$376,250
|
|
Brain Cancer
|
NCI
|
1R21CA132891-01
|
|
Effect on IL-2R Antibody on Regulatory T-cells in Patients with Malignant Gliomas
|
SAMPSON, JOHN
|
DUKE UNIVERSITY
|
NC
|
$210,600
|
|
Brain Cancer
|
NCI
|
1R21CA131999-01
|
|
Targeting cancer stem cells for brain tumor therapy
|
YU, JOHN
|
CEDARS-SINAI MEDICAL CENTER
|
CA
|
$182,813
|
|
Brain Cancer
|
NCI
|
5R01CA069495-13
|
|
Novel Effectors of GRB2 in Human Glial Tumors
|
WONG, ALBERT
|
STANFORD UNIVERSITY
|
CA
|
$316,005
|
|
Brain Cancer
|
NCI
|
5R01CA118365-02
|
|
Treatment Planning using Physiologic MRI Data
|
MEYERAND, M
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$268,227
|
|
Brain Cancer
|
NCI
|
5R01CA107268-05
|
|
Pharmacology of Targeted Therapy to Brain Tumors
|
SZOKA, FRANCIS
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$364,513
|
|
Brain Cancer
|
NCI
|
5R01CA108647-04
|
|
Rheb GTPase as chemotherapeutic target for brain tumors
|
QUILLIAM, LAWRENCE
|
INDIANA UNIV-PURDUE UNIV AT INDIANAPOLIS
|
IN
|
$224,630
|
|
Brain Cancer
|
NCI
|
5R01CA121131-03
|
|
PACAP Modulation of Shh Signaling in Medulloblastoma
|
LIAU, LINDA
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$266,286
|
|
Brain Cancer
|
NCI
|
1R21CA126716-01A1
|
|
Microfabrication Tools for In Vitro Monitoring of Cancer Cell Metabolism
|
REVZIN, ALEXANDER
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$193,303
|
|
Brain Cancer
|
NCI
|
5R01CA100426-05
|
|
Invasion and Angiogenesis in Malignant Gliomas
|
ZAGZAG, DAVID
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$262,798
|
|
Brain Cancer
|
NINDS
|
2R01NS042645-06A2
|
|
Statistical atlases of brain tumor MRI:do imaging phenotypes predict progression?
|
DAVATZIKOS, CHRISTOS
|
UNIVERSITY OF PENNSYLVANIA
|
PA
|
$344,531
|
|
Brain Cancer
|
NCI
|
1R01CA122930-01A2
|
|
Conditionally Replicative Adenoviral Vectors for Malignant Glioma
|
LESNIAK, MACIEJ
|
UNIVERSITY OF CHICAGO
|
IL
|
$323,817
|
|
Brain Cancer
|
NCI
|
1R01CA123451-01A2
|
|
Tryptophan Metabolism in Human Brain Tumors
|
JUHASZ, CSABA
|
WAYNE STATE UNIVERSITY
|
MI
|
$313,772
|
|
Brain Cancer
|
NINDS
|
5R01NS045888-04
|
|
Vascular Maintenance and Brain Tumor Refractory
|
LIN, P
|
VANDERBILT UNIVERSITY
|
TN
|
$264,875
|
|
Brain Cancer
|
NCI
|
1R01CA127716-01A1
|
|
Epigenetic regulation of temozolomide responsiveness in glioblastoma
|
SARKARIA, JANN
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
MN
|
$413,695
|
|
Brain Cancer
|
NCI
|
1R01CA122163-01A2
|
|
Allergic Condition Susceptibility Polymorphisms and Glioma Risk
|
SCHWARTZBAUM, JUDITH
|
OHIO STATE UNIVERSITY
|
OH
|
$544,169
|
|
Brain Cancer
|
NCI
|
5R01CA123396-02
|
|
CNS Anti-tumor immunity induced by dendritic cell vaccination and TLR agonists
|
PRINS, ROBERT
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$234,840
|
|
Brain Cancer
|
NINDS
|
5R01NS051470-04
|
|
INTERACTIONS OF FIBRINOGEN WITH p75NTR
|
AKASSOGLOU, KATERINA
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
CA
|
$10,743
|
|
Brain Cancer
|
NCI
|
1R01CA127369-01A1
|
|
Multifunctional Photosensitizers for Image-guided PDT of Brain Tumors
|
PANDEY, RAVINDRA
|
ROSWELL PARK CANCER INSTITUTE CORP
|
NY
|
$556,187
|
|
Brain Cancer
|
NCI
|
1R01CA127008-01A1
|
|
REGULATION AND ROLE OF MTOR IN NEUROFIBROMIN GROWTH CONTROL
|
WEBER, JASON
|
WASHINGTON UNIVERSITY
|
MO
|
$341,561
|
|
Brain Cancer
|
NCI
|
1R01CA127383-01A1
|
|
The Tumor Suppressive Role of CHD5
|
MILLS, ALEA
|
COLD SPRING HARBOR LABORATORY
|
NY
|
$348,513
|
|
Brain Cancer
|
NCI
|
5R13CA086959-09
|
|
The Annual Blood-Brain Barrier Consortium Meeting
|
NEUWELT, EDWARD
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$9,710
|
|
Brain Cancer
|
NIDCD
|
5R13CA086959-09
|
|
The Annual Blood-Brain Barrier Consortium Meeting
|
NEUWELT, EDWARD
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$4,855
|
|
Brain Cancer
|
NINDS
|
5R13CA086959-09
|
|
The Annual Blood-Brain Barrier Consortium Meeting
|
NEUWELT, EDWARD
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$10,000
|
|
Brain Cancer
|
NIAID
|
5K08AI054375-05
|
|
Immune resistance to glioma via dendritic cells
|
DHODAPKAR, KAVITA
|
ROCKEFELLER UNIVERSITY
|
NY
|
$130,464
|
|
Brain Cancer
|
NCCAM
|
1R21AT003893-01A1
|
|
Inhibiting Notch activity and brain tumor progression using Zen Sheng Ping (ZSP)
|
EBERHART, CHARLES
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$246,000
|
|
Brain Cancer
|
NCI
|
5R01CA121258-02
|
|
Cellular Transduction with Replication-Competent Retrovirus Vectors
|
KASAHARA, NORIYUKI
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$467,899
|
|
Brain Cancer
|
NCI
|
5R01CA082500-09
|
|
MRI Contrast Agent Methods of Assessing Tumor Angiogenesis
|
SCHMAINDA, KATHLEEN
|
MEDICAL COLLEGE OF WISCONSIN
|
WI
|
$283,690
|
|
Brain Cancer
|
NCI
|
1R01CA127612-01A1
|
|
Imaging and Tissue Biomarkers in Patients with Newly Diagnosed GBM
|
NELSON, SARAH
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$398,516
|
|
Brain Cancer
|
NINDS
|
5R37NS044687-26
|
|
Opening of the Blood Brain Barrier to Antitumor Agents
|
NEUWELT, EDWARD
|
OREGON HEALTH AND SCIENCE UNIVERSITY
|
OR
|
$617,969
|
|
Brain Cancer
|
NINDS
|
5R01NS051439-04
|
|
Molecular Targeting and Imaging of Pituitary Adenomas
|
OYESIKU, NELSON
|
EMORY UNIVERSITY
|
GA
|
$335,479
|
|
Brain Cancer
|
NINDS
|
5R01NS054276-03
|
|
Molecular Mechanisms of SPARC Mediated Glioma Invasion
|
RICH, JEREMY
|
DUKE UNIVERSITY
|
NC
|
$235,517
|
|
Brain Cancer
|
NINDS
|
5R01NS053727-03
|
|
Vaso-occlusive Mechanisms that Induce Hypoxia and Cause Glioma Progression.
|
BRAT, DANIEL
|
EMORY UNIVERSITY
|
GA
|
$334,267
|
|
Brain Cancer
|
NCI
|
1K07CA127468-01A1
|
|
A pilot study of statin therapy and risk of malignant glioma
|
LAI, ROSE
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
NY
|
$135,513
|
|
Brain Cancer
|
NCI
|
5R01CA074145-11
|
|
High-Grade Astrocytoma-specific Molecular Targeting
|
DEBINSKI, WALDEMAR
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$238,112
|
|
Brain Cancer
|
NCI
|
2P01CA095616-06
|
0001
|
Discovering And Modeling Genetic Events Driving Glioblastoma Pathogenesis
|
DEPINHO, RONALD
|
DANA-FARBER CANCER INSTITUTE
|
MA
|
$378,833
|
|
Brain Cancer
|
NCI
|
2P01CA095616-06
|
0002
|
Resistance To Therapeutics Directed At The EGFR/Pi3-K Pathways In Glioblastoma
|
CAVENEE, WEBSTER
|
LUDWIG INSTITUTE FOR CANCER RESEARCH
|
CA
|
$329,018
|
|
Brain Cancer
|
NCI
|
2P01CA095616-06
|
0004
|
Identification and Characterization of Kinase Oncogenes in Glioblastoma
|
CHIN, LYNDA
|
DANA-FARBER CANCER INSTITUTE
|
MA
|
$217,878
|
|
Brain Cancer
|
NCI
|
2P01CA095616-06
|
9001
|
Transgenic Mouse and Biobank Core
|
DEPINHO, RONALD
|
DANA-FARBER CANCER INSTITUTE
|
MA
|
$242,193
|
|
Brain Cancer
|
NCI
|
2P01CA095616-06
|
9002
|
Neuropathology Core
|
LOUIS, DAVID
|
DANA-FARBER CANCER INSTITUTE
|
MA
|
$100,928
|
|
Brain Cancer
|
NCI
|
2P01CA095616-06
|
9003
|
Genomics & Bioinformatics
|
BRENNAN, CAMERON
|
MEMORIAL SLOAN-KETTERING CANCER CENTER
|
NY
|
$139,483
|
|
Brain Cancer
|
NCI
|
1K08CA124479-01A1
|
|
Genome-wide promoter methylation profiling of glioma
|
LAI, ALBERT
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$136,500
|
|
Brain Cancer
|
NCI
|
5R01CA120893-02
|
|
Dendritic Cell-Brain Tumor Stem Cell Fusion Vaccines
|
PLAUTZ, GREGORY
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
OH
|
$293,550
|
|
Brain Cancer
|
NCI
|
5R01CA119298-03
|
|
Glioma Therapy Using Targeted Oncolytic HSV Vectors
|
GLORIOSO, JOSEPH
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$349,393
|
|
Brain Cancer
|
NINR
|
5R01NR009675-02
|
|
Phase III Study of Donepezil in the Irradiated Brain
|
RAPP, STEPHEN
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$353,087
|
|
Brain Cancer
|
NINDS
|
5K08NS055061-03
|
|
Macrophage and Microglial Activation in Glioma-Associated Inflammation
|
GUPTA, NALIN
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$161,406
|
|
Brain Cancer
|
NIGMS
|
5F32GM080851-02
|
|
Molecular tracking of quantum dot-linked aquaporins in living cell membranes
|
CRANE, JONATHAN
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$49,646
|
|
Brain Cancer
|
NINDS
|
5R01NS052563-03
|
|
Neural Progenitor Genes and Brain Tumors
|
KORNBLUM, HARLEY
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$233,285
|
|
Brain Cancer
|
NCI
|
1R21CA127696-01A1
|
|
The p270 SWI/SNF subunit as a potential Wilms' tumor susceptibility gene
|
MORAN, ELIZABETH
|
UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL
|
NJ
|
$175,500
|
|
Brain Cancer
|
NCI
|
5R01CA111996-03
|
|
Quantification of Tumor Malignancy with MRI
|
JOHNSON, GLYN
|
NEW YORK UNIVERSITY SCHOOL OF MEDICINE
|
NY
|
$291,780
|
|
Brain Cancer
|
NIDCD
|
5R01DC005985-04
|
|
Phenotypic Determinants of Vestibular Schwannomas
|
WELLING, D
|
OHIO STATE UNIVERSITY
|
OH
|
$301,597
|
|
Brain Cancer
|
NCI
|
5U01CA105691-05
|
|
New Approaches to Brain Tumor Therapy, NABTT CNS
|
LESSER, GLENN
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$133,650
|
|
Brain Cancer
|
NINDS
|
5R01NS042262-07
|
|
Genetics Pathways of Glioma Invasion
|
BERENS, MICHAEL
|
TRANSLATIONAL GENOMICS RESEARCH INST
|
AZ
|
$405,644
|
|
Brain Cancer
|
NCI
|
5R01CA082478-08
|
|
Program for Development of BNCT Agents
|
KAHL, STEPHEN
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$297,392
|
|
Brain Cancer
|
NCI
|
5R01CA106429-04
|
|
Molecular Mechanisms of Blockage of ErbB receptors
|
TANG, CAREEN
|
GEORGETOWN UNIVERSITY
|
DC
|
$232,510
|
|
Brain Cancer
|
NCI
|
5R01CA115438-02
|
|
Molecular Species Responsible for Tumor Supressive Effect of MnSOD
|
DOMANN, FREDERICK
|
UNIVERSITY OF IOWA
|
IA
|
$249,578
|
|
Brain Cancer
|
NCI
|
1R43CA132238-01
|
|
Inhibition of Migration for Treatment of Malignant Glioma
|
LEVIN, EUGENE
|
MOTILITY, INC.
|
CA
|
$147,000
|
|
Brain Cancer
|
NCI
|
5R01CA109745-03
|
|
Meningioma: Risk Factors and Quality of Life
|
WIEMELS, JOSEPH
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$407,894
|
|
Brain Cancer
|
NIAID
|
1R43AI077225-01
|
|
Inhibition of STAT-3 to stimulate immune function for GBM
|
BUDDE, RAYMOND
|
HOUSTON PHARMACEUTICALS, INC.
|
TX
|
$146,989
|
|
Brain Cancer
|
NINDS
|
5R01NS055095-02
|
|
Understanding and Preventing Tumor Disperal with Hydrogel Therapeutics
|
GEMEINHART, RICHARD
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$347,102
|
|
Brain Cancer
|
NCI
|
5R01CA115638-03
|
|
UNDERSTANDING TRAIL SENSITIVITY IN HUMAN GLIOMA
|
PIEPER, RUSS
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$239,527
|
|
Brain Cancer
|
NCI
|
5R01CA109748-04
|
|
The Role of Lyn in Glioma Progression and Migration
|
GLADSON, CANDECE
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$263,099
|
|
Brain Cancer
|
NINDS
|
5K08NS051477-02
|
|
Creation of a PDGF-C Autocrine Loop by HIC1 Inactivation
|
ROOD, BRIAN
|
CHILDREN'S NATIONAL MEDICAL CENTER
|
DC
|
$145,800
|
|
Brain Cancer
|
NINDS
|
1F32NS056594-01A2
|
|
The Role of Us9 in Herpesvirus Neuroinvasion
|
LYMAN, MATHEW
|
PRINCETON UNIVERSITY
|
NJ
|
$24,998
|
|
Brain Cancer
|
NCI
|
5U10CA073590-12
|
|
SWOG Institutional Grant
|
SONDAK, VERNON
|
H. LEE MOFFITT CANCER CTR & RES INST
|
FL
|
$1
|
|
Brain Cancer
|
NINDS
|
5R01NS049720-06
|
|
Xenograft Model for Studying Amplified EGFR in GBM
|
JAMES, CHARLES
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$304,644
|
|
Brain Cancer
|
NCI
|
5U10CA014028-35
|
|
Southwest Oncology Group
|
FLAHERTY, LAWRENCE
|
WAYNE STATE UNIVERSITY
|
MI
|
$217,197
|
|
Brain Cancer
|
NCCAM
|
5R01AT003899-03
|
|
Role of a Novel E3-Ubiquitin Ligase in Chemoprevention
|
HANNINK, MARK
|
UNIVERSITY OF MISSOURI-COLUMBIA
|
MO
|
$323,731
|
|
Brain Cancer
|
NCI
|
1F32CA128335-01A1
|
|
Merlin regulation of glial cell growth and motility
|
HOUSHMANDI, SHERVIN
|
WASHINGTON UNIVERSITY
|
MO
|
$49,646
|
|
Brain Cancer
|
NINDS
|
5K01NS049300-06
|
|
Multimodal replicative lytic viruses for glioma therapy
|
POST, DAWN
|
UPSTATE MEDICAL UNIVERSITY
|
NY
|
$144,145
|
|
Brain Cancer
|
NCI
|
1R43CA112827-01A2
|
|
Ultra-HTP Multiplex Approach to Small Molecule Screens
|
MIELNICKI, LAWRENCE
|
BUFFALO MOLECULAR TARGET LABORATORY
|
NY
|
$132,000
|
|
Brain Cancer
|
NINDS
|
5R01NS051520-03
|
|
PTP mu Supresses Brain Tumor Cell Migration and Dispersal
|
BRADY-KALNAY, SUSANN
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$337,544
|
|
Brain Cancer
|
NINDS
|
5K08NS046430-04
|
|
Targeted Adenoviral Gene Therapy for Malignant Glioma
|
LESNIAK, MACIEJ
|
UNIVERSITY OF CHICAGO
|
IL
|
$165,078
|
|
Brain Cancer
|
NINDS
|
5R01NS040511-09
|
|
Oligodendrocyte Lineage Gene Function in the CNS
|
ROWITCH, DAVID
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$450,697
|
|
Brain Cancer
|
NINDS
|
1F32NS059126-01A1
|
|
The Role of Id2 in Adult Neurogenesis
|
HAVRDA, MATTHEW
|
DARTMOUTH COLLEGE
|
NH
|
$46,826
|
|
Brain Cancer
|
NCI
|
1F32CA132329-01
|
|
The Role of GAB1:JNK2alpha2 Complex in Glial Tumorigenesis
|
LI, GORDON
|
STANFORD UNIVERSITY
|
CA
|
$51,278
|
|
Brain Cancer
|
NCI
|
5R01CA108637-04
|
|
Experimental Therapeutics for Brain Cancer
|
VALLERA, DANIEL
|
UNIVERSITY OF MINNESOTA TWIN CITIES
|
MN
|
$223,970
|
|
Brain Cancer
|
NINDS
|
2P01NS040923-06A1
|
0004
|
Signal transduction modulation as a therapy for malignant gliomas
|
POLLACK, IAN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$320,932
|
|
Brain Cancer
|
NINDS
|
2P01NS040923-06A1
|
0005
|
Molecularly targeted, multidisciplinary glioma vaccine approaches
|
OKADA, HIDEHO
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$243,754
|
|
Brain Cancer
|
NINDS
|
2P01NS040923-06A1
|
0006
|
Vector delivery to modify the brain tumor and its microenvironment
|
GLORIOSO, JOSEPH
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$273,580
|
|
Brain Cancer
|
NINDS
|
2P01NS040923-06A1
|
9005
|
Cellular and tissue imaging
|
WATKINS, SIMON
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$113,367
|
|
Brain Cancer
|
NINDS
|
2P01NS040923-06A1
|
9006
|
Immunological monitoring and cellular products laboratory
|
WHITESIDE, THERESA
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$123,343
|
|
Brain Cancer
|
NCI
|
5R01CA107193-04
|
|
Signal Transduction of the Netrin Pathway
|
WU, JANE
|
NORTHWESTERN UNIVERSITY
|
IL
|
$274,457
|
|
Brain Cancer
|
NCI
|
5R01CA111835-03
|
|
The Role of PDGFR in Medulloblastoma Progression
|
MACDONALD, TOBEY
|
CHILDREN'S RESEARCH INSTITUTE
|
DC
|
$257,494
|
|
Brain Cancer
|
NCI
|
5R01CA105607-05
|
|
Genomic-wide Kinase Sequencing of Pediatric Brain Tumors
|
ROBERTS, THOMAS
|
DANA-FARBER CANCER INSTITUTE
|
MA
|
$691,465
|
|
Brain Cancer
|
NIGMS
|
5R01GM080462-02
|
|
Regulation of TGF-beta Signaling and Embryonic Development by GTPases
|
THOMSEN, GERALD
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
NY
|
$289,308
|
|
Brain Cancer
|
NCI
|
5R01CA103956-04
|
|
FAK and Pky2 in Determination of Glioblastoma Phenotype
|
LOFTUS, JOSEPH
|
MAYO CLINIC COLL OF MED, MAYO CLINIC AZ
|
AZ
|
$264,504
|
|
Brain Cancer
|
NCI
|
5R01CA108558-05
|
|
Treatment of Malignant Gliomas with 2-5A-anti-hTR
|
BOGLER, OLIVER
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$293,510
|
|
Brain Cancer
|
NCI
|
5R01CA112358-03
|
|
Dendritic Cell Vaccine Targeting Melanoma-Associated Antigens in Malignant Glioma
|
LIAU, LINDA
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$253,548
|
|
Brain Cancer
|
NCI
|
5R01CA109461-03
|
|
Meningioma: Risk Factors and Quality of Life
|
BLACK, PETER
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$224,348
|
|
Brain Cancer
|
NCI
|
5R01CA075557-11
|
|
Role of uPA and uPAR in Human Glioma Invasiveness
|
RAO, JASTI
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$231,475
|
|
Brain Cancer
|
NCI
|
5R01CA116708-04
|
|
Cath B and muPAR siRNA constructs regressed glioma growth
|
RAO, JASTI
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$290,262
|
|
Brain Cancer
|
NCI
|
5R01CA112350-04
|
|
bHLH Factors in Medulloblastoma Genesis and Maintenance
|
OLSON, JAMES
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$310,300
|
|
Brain Cancer
|
NINDS
|
5R01NS030245-19
|
|
Temodar Resistance in CNS Tumors
|
FRIEDMAN, HENRY
|
DUKE UNIVERSITY
|
NC
|
$292,039
|
|
Brain Cancer
|
NCI
|
5R01CA108633-04
|
|
Signal Transduction Pathways in Glioblastoma
|
CHAKRAVARTI, ARNAB
|
BRIGHAM AND WOMEN'S HOSPITAL
|
MA
|
$445,200
|
|
Brain Cancer
|
NCI
|
5R01CA107570-05
|
|
Drug carrier of blood/tumor/brain permeability
|
STRAUBINGER, ROBERT
|
STATE UNIVERSITY OF NEW YORK AT BUFFALO
|
NY
|
$290,879
|
|
Brain Cancer
|
NCI
|
5R01CA113321-04
|
|
Mechanisms of Radiation-Induced Cognitive Dysfunction
|
BROWN, WILLIAM
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$214,982
|
|
Brain Cancer
|
NIEHS
|
2P42ES007380-12
|
0009
|
Project 3: Vascular Mechanisms of PCB-Induced Brain Metastases
|
TOBOREK, MICHAL
|
UNIVERSITY OF KENTUCKY
|
KY
|
$258,605
|
|
Brain Cancer
|
NCI
|
5R01CA116724-03
|
|
Gene-Environment Factors in Childhood Brain Tumors
|
MUELLER, BETH
|
FRED HUTCHINSON CANCER RESEARCH CENTER
|
WA
|
$185,734
|
|
Brain Cancer
|
NCI
|
5R01CA102673-05
|
|
Imaging Signaling Changes in Cancer and Treatment
|
BLASBERG, RONALD
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
NY
|
$495,266
|
|
Brain Cancer
|
NCI
|
5R01CA116257-03
|
|
Lactate Transport as a Therapeutic Target in Glioma
|
MATHUPALA, SAROJ
|
WAYNE STATE UNIVERSITY
|
MI
|
$234,525
|
|
Brain Cancer
|
NCI
|
5R01CA052689-18
|
|
Genetic and Molecular Epidemiology of Adult Glioma
|
WRENSCH, MARGARET
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$1,133,948
|
|
Brain Cancer
|
NCI
|
5R01CA078524-09
|
|
Structure, Function and Regulation of Merlin
|
IP, WALLACE
|
UNIVERSITY OF CINCINNATI
|
OH
|
$262,736
|
|
Brain Cancer
|
NCI
|
5R01CA109473-03
|
|
Meningioma: Risk Factors and Quality of Life
|
BONDY, MELISSA
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$232,676
|
|
Brain Cancer
|
NINDS
|
5R01NS054009-02
|
|
CNS Radiation Injury: Regeneration via Human ES Cells
|
TABAR, VIVIANE
|
SLOAN-KETTERING INSTITUTE FOR CANCER RES
|
NY
|
$323,750
|
|
Brain Cancer
|
NINDS
|
5F31NS056678-02
|
|
Effects of AT1R Blockade on WBI-induced Brain Injury
|
CONNER, KELLY
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$35,572
|
|
Brain Cancer
|
NIEHS
|
5R01ES005865-15
|
|
Repair of DNA Damage Induced By Environmental Agents
|
LEDOUX, SUSAN
|
UNIVERSITY OF SOUTH ALABAMA
|
AL
|
$327,397
|
|
Brain Cancer
|
NCI
|
5R01CA108500-06
|
|
Regulation of RTKs by the SETA/CIN85 Complex in Glioma
|
BOGLER, OLIVER
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$213,815
|
|
Brain Cancer
|
NCI
|
5R01CA108622-04
|
|
SOMATIC CELL TRANSFER TO MODEL MEDULLOBLASTOMA IN MICE
|
FULTS, DANIEL
|
UNIVERSITY OF UTAH
|
UT
|
$213,338
|
|
Brain Cancer
|
NCI
|
5R01CA109475-03
|
|
Meningioma: Risk Factors and Quality of Life
|
SCHILDKRAUT, JOELLEN
|
DUKE UNIVERSITY
|
NC
|
$288,817
|
|
Brain Cancer
|
NCI
|
5R01CA120919-03
|
|
Oxygen Guided Hypofractionated Radiotherapy for Gliomas
|
KHAN, MOHAMMAD
|
DARTMOUTH COLLEGE
|
NH
|
$275,593
|
|
Brain Cancer
|
NINDS
|
5R01NS049514-03
|
|
Serum markers of brain barriers
|
JANIGRO, DAMIR
|
CLEVELAND CLINIC LERNER COL/MED-CWRU
|
OH
|
$337,544
|
|
Brain Cancer
|
NCI
|
5U10CA016116-35
|
|
Eastern Cooperative Oncology Group
|
FORASTIERE, ARLENE
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$279,595
|
|
Brain Cancer
|
NINDS
|
5R01NS048921-05
|
|
Heparan Sulfate Proteoglycans in Glioma Angiogenesis
|
FRIEDL, ANDREAS
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$245,360
|
|
Brain Cancer
|
NCI
|
5U10CA021076-33
|
|
EASTERN COOPERATIVE ONCOLOGY GROUP - WISCONSIN STUDIES
|
KAHL, BRAD
|
UNIVERSITY OF WISCONSIN MADISON
|
WI
|
$610,603
|
|
Brain Cancer
|
NCI
|
5R01CA118822-03
|
|
The Role of OTX2 in Molecular Pathogenesis of Medulloblastoma
|
YAN, HAI
|
DUKE UNIVERSITY
|
NC
|
$215,096
|
|
Brain Cancer
|
NINDS
|
5R01NS055140-02
|
|
Giloma Vaccines in Combination with Poly-ICLC
|
OKADA, HIDEHO
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$324,844
|
|
Brain Cancer
|
NINDS
|
5R01NS047699-05
|
|
Inhibition of glioma tumor growth by antisense MMP-9
|
RAO, JASTI
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$339,063
|
|
Brain Cancer
|
NCI
|
5R01CA098568-05
|
|
Brain tumor angiogenesis: Integrin ceramide signaling
|
ERDREICH-EPSTEIN, ANAT
|
CHILDREN'S HOSPITAL LOS ANGELES
|
CA
|
$266,432
|
|
Brain Cancer
|
NCI
|
5R21CA126127-02
|
|
Predictive Markers of Glioblastoma Response to VEGF Trap
|
DE GROOT, JOHN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$292,600
|
|
Brain Cancer
|
NCI
|
5R01CA116174-02
|
|
Southeast Region Case-Control Study of Adult Glioma
|
EGAN, KATHLEEN
|
H. LEE MOFFITT CANCER CTR & RES INST
|
FL
|
$807,598
|
|
Brain Cancer
|
NCI
|
5R01CA119990-03
|
|
Neural Predictors and RAS Modulation of Radiation-induced Cognitive Impairment
|
BRUNSO-BECHTOLD, JUDY
|
WAKE FOREST UNIVERSITY HEALTH SCIENCES
|
NC
|
$247,327
|
|
Brain Cancer
|
NIAID
|
5R01AI058256-03
|
|
Viral-based Chemokine Receptor Antagonists
|
HARRISON, JEFFREY
|
UNIVERSITY OF FLORIDA
|
FL
|
$383,587
|
|
Brain Cancer
|
NINDS
|
5R01NS053900-03
|
|
Cellular and molecular basis of malignant astrocytoma
|
ZHU, YUAN
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$309,361
|
|
Brain Cancer
|
NCI
|
5R21CA126115-02
|
|
Image Localization for Pathologic Correlation of Delta-24-RGD
|
CONRAD, CHARLES
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$292,600
|
|
Brain Cancer
|
NCI
|
5F32CA121769-02
|
|
Identification and characterization of activated tyrosine kinases in glioblastoma
|
STOMMEL, JAYNE
|
DANA-FARBER CANCER INSTITUTE
|
MA
|
$11,757
|
|
Brain Cancer
|
NINDS
|
5R01NS052323-03
|
|
Control of Medulloblastoma Migration & Survival by Unc5c
|
WECHSLER-REYA, ROBERT
|
DUKE UNIVERSITY
|
NC
|
$340,821
|
|
Brain Cancer
|
NCI
|
5R01CA107183-04
|
|
Targeting Glioma by Anti-MMPs-2 and -9 DNAzymes
|
POURMOTABBED, TAYEBEH
|
UNIVERSITY OF TENNESSEE HEALTH SCI CTR
|
TN
|
$246,068
|
|
Brain Cancer
|
NCI
|
5R01CA068490-13
|
|
Functional Analysis of the Von Hippel-Lindau Protein
|
KAELIN, WILLIAM
|
DANA-FARBER CANCER INSTITUTE
|
MA
|
$297,903
|
|
Brain Cancer
|
NCI
|
1R01CA132853-01
|
|
Regulation of medulloblastoma tumor growth by SPARC
|
LAKKA, SAJANI
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$260,620
|
|
Brain Cancer
|
NCI
|
5R01CA111700-04
|
|
MECHANISM OF ANTI-APOPTOTIC FUNCTION OF GRP78/BiP
|
LEE, AMY
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
CA
|
$270,000
|
|
Brain Cancer
|
NICHD
|
5R01HD034283-13
|
|
CELL-SPECIFIC EXPRESSION IN THE PITUITARY GLAND
|
CAMPER, SALLY
|
UNIVERSITY OF MICHIGAN AT ANN ARBOR
|
MI
|
$298,285
|
|
Brain Cancer
|
NINDS
|
1R01NS061835-01
|
|
Regression of meningioma tumor growth by combination therapy
|
RAO, JASTI
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$343,438
|
|
Brain Cancer
|
NCI
|
5R01CA113382-03
|
|
Perivascular Invasion of GBMs
|
BERGERS, GABRIELE
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$266,285
|
|
Brain Cancer
|
NINDS
|
5T32NS048039-02
|
|
Training Program in Brain Tumor Biology
|
BENVENISTE, ETTY
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$276,905
|
|
Brain Cancer
|
NCI
|
1R01CA132878-01
|
|
Structural Biology of Lysine Methylation in DNA Damage and Checkpoint Signaling
|
MER, GEORGES
|
MAYO CLINIC COLL OF MEDICINE, ROCHESTER
|
MN
|
$313,533
|
|
Brain Cancer
|
NINDS
|
5R01NS055089-02
|
|
Notch signaling in brain tumors
|
EBERHART, CHARLES
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$358,750
|
|
Brain Cancer
|
NINDS
|
5R01NS052738-02
|
|
Role of cell cycle inhibitors in adult neural stem cells
|
CASACCIA-BONNEFIL, PATRIZIA
|
UNIV OF MED/DENT NJ-R W JOHNSON MED SCH
|
NJ
|
$13,606
|
|
Brain Cancer
|
NCI
|
5R01CA068682-18
|
|
Biomedical Applications of Expanded Porphyrins
|
SESSLER, JONATHAN
|
UNIVERSITY OF TEXAS AUSTIN
|
TX
|
$305,354
|
|
Brain Cancer
|
NCI
|
5K01CA098092-05
|
|
Bcl-2 family proteins in the ER-mediated apoptosis
|
ZONG, WEI-XING
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
NY
|
$124,308
|
|
Brain Cancer
|
NCI
|
5R01CA029088-25
|
|
DNA Damage: Roles in Toxicity and Mutagenicity
|
GOLD, BARRY
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$269,905
|
|
Brain Cancer
|
NCI
|
7U01CA084292-10
|
|
Control of Protein Translation in Cancer Pathogenesis
|
PANDOLFI, PIER PAOLO
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
MA
|
$697,531
|
|
Brain Cancer
|
NINDS
|
5R01NS052634-04
|
|
Amino-acid Transport and the Biology of Human Gliomas
|
SONTHEIMER, HARALD
|
UNIVERSITY OF ALABAMA AT BIRMINGHAM
|
AL
|
$356,757
|
|
Brain Cancer
|
NCI
|
5R01CA072937-08
|
|
Interactions Between Cytotoxic and Antiangiogenic Drugs
|
GALLO, JAMES
|
TEMPLE UNIVERSITY
|
PA
|
$203,350
|
|
Brain Cancer
|
NCI
|
5R01CA102011-05
|
|
Angiopoietin-2 and Glioma Invasion
|
CHENG, SHI-YUAN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
PA
|
$288,651
|
|
Brain Cancer
|
NINDS
|
5R01NS052507-03
|
|
Glioblastoma Genome Project to Locate Molecular Targets
|
RIGGINS, GREGORY
|
JOHNS HOPKINS UNIVERSITY
|
MD
|
$580,438
|
|
Brain Cancer
|
NCI
|
5R21CA121561-02
|
|
Image Guided determination of Functional Pathways in Neurological Oncology
|
HENRY, ROLAND
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$290,115
|
|
Brain Cancer
|
NINDS
|
5R01NS057529-03
|
|
Growth inhibition of brain tumors by cord blood stem cells
|
RAO, JASTI
|
UNIVERSITY OF ILLINOIS AT CHICAGO
|
IL
|
$390,181
|
|
Brain Cancer
|
NCI
|
5R01CA086357-09
|
|
Modulating Base Excision Repair in Tumor Drug Resistance
|
GERSON, STANTON
|
CASE WESTERN RESERVE UNIVERSITY
|
OH
|
$261,129
|
|
Brain Cancer
|
NCI
|
1R21CA133173-01
|
|
Molecular Profiling and Candidate Gene Analysis in Pediatric Gliomas
|
BIEGEL, JACLYN
|
CHILDREN'S HOSPITAL OF PHILADELPHIA
|
PA
|
$222,188
|
|
Brain Cancer
|
NINDS
|
5F31NS056581-03
|
|
Characterization of a novel EGFR variant in Glioblastoma
|
PICCIONE, EMILY
|
STANFORD UNIVERSITY
|
CA
|
$53,450
|
|
Brain Cancer
|
NCI
|
5R01CA116041-03
|
|
Identification of MRS Markers of Glioma Progression
|
MCKNIGHT, TRACY
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$215,196
|
|
Brain Cancer
|
NCI
|
1P50CA127001-01A1
|
0001
|
Tropism Enhanced Oncolytic Adenovirus for the treatment of Brain Tumors
|
FUEYO, JUAN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$180,033
|
|
Brain Cancer
|
NCI
|
1P50CA127001-01A1
|
0002
|
Targeting the PI3 pathway in Gliomas with PI3 inhibitors and rational combination
|
YUNG, W K
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$190,893
|
|
Brain Cancer
|
NCI
|
1P50CA127001-01A1
|
0003
|
Prediction of Chemoradiation response in Glioblastoma to individualize Therapy
|
ALDAPE, KENNETH
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$272,685
|
|
Brain Cancer
|
NCI
|
1P50CA127001-01A1
|
0004
|
Genetic Modulation of Cognitive Function and outcomes in Glioblastoma Patients
|
BONDY, MELISSA
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$224,839
|
|
Brain Cancer
|
NCI
|
1P50CA127001-01A1
|
0005
|
CB: Pathology and Tissue Procurement Core
|
ALDAPE, KENNETH
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$123,850
|
|
Brain Cancer
|
NCI
|
1P50CA127001-01A1
|
9001
|
CA: Administrative Core
|
BOGLER, OLIVER
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$97,565
|
|
Brain Cancer
|
NCI
|
1P50CA127001-01A1
|
9002
|
CC: Biostatistics Core
|
HESS, KENNETH
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$58,813
|
|
Brain Cancer
|
NCI
|
1P50CA127001-01A1
|
9003
|
CD: Clinical Core
|
GILBERT, MARK
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$97,648
|
|
Brain Cancer
|
NCI
|
1P50CA127001-01A1
|
9004
|
CE: Animal Core
|
LANG, FREDERICK
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$120,166
|
|
Brain Cancer
|
NCI
|
1P50CA127001-01A1
|
0006
|
Developmental Research program
|
BOGLER, OLIVER
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$98,097
|
|
Brain Cancer
|
NCI
|
1P50CA127001-01A1
|
0007
|
Career Development Program
|
YUNG, W K
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
TX
|
$98,097
|
|
Brain Cancer
|
NCI
|
7R01NS054543-04
|
|
Identification of Novel Genetic Biomarkers in Brain Tumors
|
COWELL, JOHN
|
MEDICAL COLLEGE OF GEORGIA (MCG)
|
GA
|
$97,650
|
|
Brain Cancer
|
NINDS
|
7R01NS054543-04
|
|
Identification of Novel Genetic Biomarkers in Brain Tumors
|
COWELL, JOHN
|
MEDICAL COLLEGE OF GEORGIA (MCG)
|
GA
|
$204,000
|
|
Brain Cancer
|
NCI
|
5R01CA122513-02
|
|
Ultra-fast 15N Imaging in Choline in Cancer
|
ROSS, BRIAN
|
HUNTINGTON MEDICAL RESEARCH INSTITUTES
|
CA
|
$258,039
|
|
Brain Cancer
|
NINDS
|
5F32NS058042-02
|
|
p53, Rb and Ras Pathways in Neural Stem Cell Homeostasis and Transformation
|
VENERE, MONICA
|
UNIVERSITY OF CALIFORNIA SAN FRANCISCO
|
CA
|
$51,278
|
|
Brain Cancer
|
NCI
|
5R01CA109467-05
|
|
GENOMIC ANALYSIS OF MEDULLOBLASTOMAS
|
POMEROY, SCOTT
|
CHILDREN'S HOSPITAL BOSTON
|
MA
|
$744,419
|
|
Brain Cancer
|
NINDS
|
2P01NS024279-20A2
|
0014
|
Molecular Genetics Of Meningioma and Neurofibromatosis Related Disorders
|
GUSELLA, JAMES
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$379,828
|
|
Brain Cancer
|
NINDS
|
2P01NS024279-20A2
|
0016
|
Vector Query and Therapy For TSC and NF2 Lesions
|
BREAKEFIELD, XANDRA
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$291,359
|
|
Brain Cancer
|
NINDS
|
2P01NS024279-20A2
|
9009
|
CLINICAL CORE
|
THIELE, ELIZABETH
|
MASSACHUSETTS GENERAL HOSPITAL
|
MA
|
$164,880
|
|
Brain Cancer
|
NCI
|
5K01CA111402-03
|
|
Immune targeting of melanoma-associated antigens in glioma
|
PRINS, ROBERT
|
UNIVERSITY OF CALIFORNIA LOS ANGELES
|
CA
|
$148,770
|
|
Brain Cancer
|
NCI
|
5K01CA114400-04
|
|
Analyzing Myc function in neural cancers and development
|
KNOEPFLER, PAUL
|
UNIVERSITY OF CALIFORNIA DAVIS
|
CA
|
$154,780
|
|
Brain Cancer
|
NCI
|
5R01CA124832-02
|
|
Using Insights from EGFRvIII to Improve EGFR Directed Therapy in Human Gliomas
|
WONG, ALBERT
|
STANFORD UNIVERSITY
|
CA
|
$300,991
|
|
Brain Cancer
|
NCI
|
5R01CA119046-03
|
|
DIFFUSION MRI AS BIOMARKER FOR THERAPY RESPONSE IN BREAST CANCER METASTASES
|
STOPECK, ALISON
|
UNIVERSITY OF ARIZONA
|
AZ
|
$341,662
|
|
Brain Cancer
|
NCI
|
5R01CA112182-04
|
|
Neurobehavioral Late-Effects in Pediatric Brain Tumors
|
RIS, M
|
CHILDREN'S HOSPITAL MED CTR (CINCINNATI)
|
OH
|
$492,333
|
|
Brain Cancer
|
NCI
|
5R01CA121781-02
|
|
Genetic Events in the Development of Renal Cell Carcinoma
|
RATHMELL, WENDY
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$276,155
|
|
Brain Cancer
|
NCI
|
5R01CA109468-03
|
|
Meningioma: Risk Factors and Quality of Life
|
CLAUS, ELIZABETH
|
YALE UNIVERSITY
|
CT
|
$690,871
|
|
Brain Cancer
|
NCI
|
5R01CA129541-02
|
|
An investigation of radial glia as the source of ependymoma stem cells
|
GILBERTSON, RICHARD
|
ST. JUDE CHILDREN'S RESEARCH HOSPITAL
|
TN
|
$318,725
|
|
Brain Cancer
|
NCI
|
5R01CA104593-05
|
|
Ape1, oxidative stress and glioma alkylator resistance
|
SILBER, JOHN
|
UNIVERSITY OF WASHINGTON
|
WA
|
$283,597
|
|
Brain Cancer
|
NIBIB
|
5R01EB000219-11
|
|
3D Cerebral Vessel Location for Surgical Planning
|
BULLITT, ELIZABETH
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
NC
|
$480,019
|
|
Brain Cancer
|
NCI
|
5R01CA115745-03
|
|
Blood Flow MRI for Monitoring Glioma Angiogenesis
|
ALSOP, DAVID
|
BETH ISRAEL DEACONESS MEDICAL CENTER
|
MA
|
$335,708
|
|
